Cargando…
Strategies to Advance Drug Discovery in Rare Monogenic Intellectual Disability Syndromes
Some intellectual disability syndromes are caused by a mutation in a single gene and have been the focus of therapeutic intervention attempts, such as Fragile X and Rett Syndrome, albeit with limited success. The rate at which new drugs are discovered and tested in humans for intellectual disability...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836272/ https://www.ncbi.nlm.nih.gov/pubmed/29040584 http://dx.doi.org/10.1093/ijnp/pyx090 |